This biochemical is responsible for the transport of fatty acids from a cell's cytoplasm into mitochondria, where they are oxidised to produce energy
Research published in medical journals has shown that patients using semaglutide for weight loss experienced not only physical improvements but also marked reductions in symptoms of depression and anxiety
Patients with a history or family history of medullary thyroid cancer, multiple endocrine neoplasia, pancreatitis, or on dialysis are not candidates for Semaglutide
Ayesha Bryant, MSPH, MD, is a physician, clinical scientist, and associate professor passionate about bridging medical science and everyday health
Semaglutide GLP-1 is a GLP-1 receptor agonist that works by regulating appetite and promoting weight loss, and it is administered through a once-weekly injection